Humanwell unit Yichang Renfu wins China nod for labor pain trial of sufentanil injectionPUBT·Aug 12 at 09:00 AM600079-0.58%
Humanwell unit Hubei Bio-Pharma Industry Tech Institute wins China approval to start trials of HWS113 injection for chronic pruritusPUBT·Jun 29 at 01:42 PM600079-0.58%
HWHG: Pregabalin sustained-release tablets have received the drug clinical trial approval noticeZhitong·Nov 3, 2025 at 07:45 AM600079-0.58%
HWHG: Shareholders holding more than 5% of shares have completed the commitment to acquire Wuhu Xinfeng's stakeZhitong·Oct 30, 2025 at 07:47 AM600079-0.58%
HWHG: Dapoxetine Hydrochloride Tablets have obtained the drug registration certificateZhitong·Oct 13, 2025 at 09:47 AM600079-0.58%
HWHG: Oxcarbazepine extended-release tablets received a tentative approval number from the U.S. FDAZhitong·Sep 19, 2025 at 07:38 AM600079-0.58%
HWHG: Flurbiprofen Ester Injection has obtained a drug registration certificateZhitong·Sep 16, 2025 at 08:19 AM600079-0.58%
HWHG: Levonorgestrel tablets have obtained a drug registration certificateZhitong·Sep 16, 2025 at 08:19 AM600079-0.58%
HWHG: Yu Can Granules enter Phase II clinical trial researchZhitong·Sep 9, 2025 at 07:54 AM600079-0.58%
The three major A-share indices closed mixed, with WESTERN REGION GOLD hitting the daily limit36Kr·Sep 3, 2025 at 07:06 AM601069-2.00%600079-0.58%
The concept of innovative drugs rebounds, BHC and HWHG hit the limit upZhitong·Sep 3, 2025 at 02:53 AM600721-0.85%600079-0.58%
HWHG: Eicosapentaenoic Acid Ethyl Ester Soft Capsules Obtain Drug Registration CertificateZhitong·Sep 2, 2025 at 09:02 AM600079-0.58%
HWHG: The injectable remimazolam benzenesulfonate has received a drug registration certificate for new indicationsZhitong·Aug 25, 2025 at 08:48 AM600079-0.58%
HWHG: HW241045 tablets have received approval for clinical trialsZhitong·Aug 5, 2025 at 07:53 AM600079-0.58%
JD.com and HWHG hold talks on full-chain cooperation in the pharmaceutical fieldAASTOCKS·Aug 3, 2025 at 11:16 PM600079-0.58%JD-0.32%
